PeptiDream
Update in progress4587.T (Tokyo)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryBiotechnology
PeptiDream Inc., based in Kawasaki, Japan, is a biopharmaceutical company that discovers and develops constrained peptides, small molecules, and peptide-drug conjugates. Its Peptide Discovery Platform System enables synthesis of diverse macrocyclic libraries and rapid screening for potent, selective hits. The firm pursues oncology and radiopharmaceutical programs across preclinical to phase 3, plus RI and non-RI drug development and manufacturing.
Company score
- Sentiment
- 0.42
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.03
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.12
- Governance
- 0.08
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.07
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.24
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketTokyo (JPX)
- LocationJapan
- CEODr. Patrick Crawford Reid Ph.D.
- Founded2006
- Employees763
- Websitewww.peptidream.com
Identifiers
- ISINJP3836750004